CINXE.COM

<!DOCTYPE html><html lang="en-US"><head><title>Just a moment...</title><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="robots" content="noindex,nofollow"><meta name="viewport" content="width=device-width,initial-scale=1"><style>*{box-sizing:border-box;margin:0;padding:0}html{line-height:1.15;-webkit-text-size-adjust:100%;color:#313131;font-family:system-ui,-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Helvetica Neue,Arial,Noto Sans,sans-serif,Apple Color Emoji,Segoe UI Emoji,Segoe UI Symbol,Noto Color Emoji}body{display:flex;flex-direction:column;height:100vh;min-height:100vh}.main-content{margin:8rem auto;max-width:60rem;padding-left:1.5rem}@media (width <= 720px){.main-content{margin-top:4rem}}.h2{font-size:1.5rem;font-weight:500;line-height:2.25rem}@media (width <= 720px){.h2{font-size:1.25rem;line-height:1.5rem}}#challenge-error-text{background-image:url(data:image/svg+xml;base64,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);background-repeat:no-repeat;background-size:contain;padding-left:34px}@media (prefers-color-scheme:dark){body{background-color:#222;color:#d9d9d9}}</style><meta http-equiv="refresh" content="120"></head><body class="no-js"><div class="main-wrapper" role="main"><div class="main-content"><noscript><div class="h2"><span id="challenge-error-text">Enable JavaScript and cookies to continue</span></div></noscript></div></div><script>(function(){window._cf_chl_opt={cvId: '3',cZone: "publications.waset.org",cType: 'non-interactive',cRay: '913498c84864fe0c',cH: 'SIoVcKh8WZqOnmd9YMGUP37O1_oo2HmzVXPLhJWrGkc-1739782928-1.2.1.1-s0UwLfx2gfDp5xl_zbNxtrCeIPX3BEabiYyM0jlK_RflYuUaG.fU17RB5EBmmVqD',cUPMDTk: "\/abstracts\/57804\/effect-on-tolerability-and-adverse-events-in-participants-receiving-naltrexonebupropion-and-antidepressant-medication-including-ssris-in-a-large-randomized-double-blind-study?__cf_chl_tk=BMPyuTT39ZiZoo6U8Af3MsdgRdUWbL6.vcAGo3o.Z00-1739782928-1.0.1.1-_iyWjpfimUJGEUAjpZV3HOo6hchJnY5Y_c84BsOR7FA",cFPWv: 'b',cITimeS: '1739782928',cTTimeMs: '1000',cMTimeMs: '120000',cTplC: 0,cTplV: 5,cTplB: 'cf',cK: "",fa: "\/abstracts\/57804\/effect-on-tolerability-and-adverse-events-in-participants-receiving-naltrexonebupropion-and-antidepressant-medication-including-ssris-in-a-large-randomized-double-blind-study?__cf_chl_f_tk=BMPyuTT39ZiZoo6U8Af3MsdgRdUWbL6.vcAGo3o.Z00-1739782928-1.0.1.1-_iyWjpfimUJGEUAjpZV3HOo6hchJnY5Y_c84BsOR7FA",md: "jUI985fDzLRlWxDCIdaIamEU7t2rFhTGWsZbNYQ.6c0-1739782928-1.2.1.1-dSjUdgIFLkFjtg9o_UvQzuhJ38uZaDszCboeSpwz0d.uivCnNisht2V5wdZVtSUJgGuLPm95HpoN4XMqdkPzVkOE36p4tnHmvpSh8q6k4RAcGBgYKkWjtOas7xAiH8Bv3HUIYEmBckdpkDL4.e9F3cKGhgHV8uz8qllJ84NOONlQoB8dlt9ja8f8vlogpjDd.gOd.7pdu9QPqT3x7BNiITYnFRxL1J1my5jtUfFFpuEt5kjC6ZmUH3ZjvGSeQBcVnH6AH3bjZEAAn_PNIme1pgD7w4CLdA40NHtBI8WCwXVvYcF4sZDPYmd5ENeynFwF0IYwGbDMgMhIJU6Qq358nlOMePQOb2LruUH_oYwhCRLbHNrcgZXC60FjE6X3oI3ZPTkuNXpsUxLrwiW99PsCN.FyyIC7wpYts85JHj3JbPsAiYrUpiVJ067TDQK9hwdaKckt5A.eF5R.TTCUjJjIyGAc2nuQr8manzkam2fVigwOghQjdGOorszeRiyT7xoN5XrqrHYoKMfDXfw8wBEQgTZxN6tXvwv2yx0rdBSCCy.BWrh2vid9xOygt2HB6UOf3U5VbvmgDPLJfTYEj3aEjEwYitUbASjOnbOsTXDf9GwMen4PHa9xIz.QtrCmesjAmfDWiTEW4FekoCYF3ckPuVizBXmPEmIClTXtZeSUED_m6wHaKJFoZxpK_DYxxqQCAjOhV_LqGBVOiBPKepzzx5GTvno26wxBxJ7iepMNDgY86ZMhSBfnR8FpUoUuN7EUycyUd1WR5jjDj9vOEg1YXc4YqrZaLChk2Y653oSlTtSiJEycZ1qQkWrmmyIh0VteVP7jtcx0bSuA47awy9QehQGi0E7sdjsF14wQnuEkW0ithOZFoN6XHDUSGmZL6E0Ub6B3khUOPc5Ces8YPgisQt00H2G.eH1lCaQZj3rFgKKCns0OSSQUjmABS3G.8fs8CUpC9Xm7vkNfRHcCAidDa8DveVepw1BXgPmO4RWxE_2PLyG0qcm22BYlRNYZolU9nLA_c0UQT9izwYANGc44Aa89b5DFozFhsFRMbXRpnY1WFR3BdzFwWDwAesWn8f7S_PzBMVPd_cDq4hECXobAkw3aqr6zUfbOBIF0T7jA8mUSRLSPs6ngq7Pkjpv_kRsbb6uqPWqEoeUxpphLKf4gulDDpARzQTsJ_hDWWtV_R6IRc1ABLYs5PynSnhuFVuUE_9jKDwUL2ZJ5T9VtAP40n22GRDRsapAhcub2kOqp7fijSFOF.QGqFminhByp7KiyaZ9PzADX.X3OvKDQXMFdPmnE1UmHFJMcENuwAQtSA8z0qPhemdxTEm6BABkGw3UTXi_q9EkQHjBXro9JQl5yNbLglDLmK1DX0KyCm_lL4Wyf1pJZy2uYHDNPBIsGqEJ9uEFPNxvrvQd7nwgLtL7ImJLz07QnKrxwCjRu5eR7wzNSE01r6I1lqGW9PUFEBxhHrcxVcBicGgQvzjOT8U1NxKKmQJnafBZPBCrBGz4QD5HVQTUFYKaD5SVtN22xj.kQy6OX0ofCcr259tNE6O70UB_UYk05CJxq7a4UUtEG.wvN0y1dnrE5Ro1klibIsclXwMtqjKv00rF6W_6rt2I29XRFWtEELz7O8KHCqm.cjTNBxA_aRKQJH2Bo_ucDLa6VB0XD0jrVapJTMLferb_34bXyt88369JCUALJXWWCP4ZVeLbMVYjgyy2XPxCZ5dPo6m8vVNkINoUuWv7RXHG7nZ7XlhlyxyZKphlzTjhPcFW51ONcS3zgNw7lH7Z2HZ13vNOLyIxGAj5dSVHSLroKRDHHdF6wM_EJponmYstcxbOSxmiyLPychktKQNuPQmx50Sg7aetWnG4_MlwPW4BsOJEqfXIWnmvJ0eBrlRylCgk1kDY6G9eFosYJVnCT1sWOAhEbp46oc.VEs6vPBjzukbilJIPd6wb3fTLkxli47Y0cEumrmLV3.7LBYjRFQxC6TvjZ4Yk1s.el9wj6Q2Za53WGPmS5T41IQgS7gOCI.L50UQlKBCQoUKf8MIqmQZ6kBMtfiN08Ff4vRDGA6iw5G31lohCxbboJh5Gce_ISay4j5L5eenbGT8Wlm3Cg3nvypnMstJkHk1DMXWznaEL0bTv_aUnxCPHT00kgjs6dnPeW82.m8ByUNhQlo5TSlWpseyc5TSnES7Y4wpSRrjtSC_9awxGVaQTBV4eh6VWNksx6ZA0ir9rezMHvLstWkkVlWMix.3nfxLvBT3fL0nFv0JZ1EDC.MVntGe4X7brIRL_axOTtI5by1qph2VZO5KwC3O.PUCVLpucMx1umPKgP1qYL277cxeD45zv6stNfbVclEGnFLYD0qxMD2YWpFM0r",mdrd: "3A8RE2vj4ZELvitxxOOmC5uQvmpVu.WqCQQsaMgdviU-1739782928-1.2.1.1-GwbDvw10O_aLWXWFZ2cPBjsWkimG6srQ0mhCj.9Ef5Ljreen9jVT2yvYLluCNCQYkUfz46RSXUOTKKbzGnB5foDAfCY4flBTTi7D.B9B3673jZ4VfI3QIcISxqoWczFA9vyXpAUtuL475DaLX4ANF_xO.7RNjkUyrMCutCyxXrVUvhV8wtQ11thx2UXIgYfRpLFrF0UxTN8GEa9WZrsovUCcpJdDaUCjewJ9NGyOA_JbMsEkmJDBkquuP8EHQkqSMu612BcpD0Mk3cL95YOzvu6KSJqlF4KYuV_mqTeA0_AUR80Pu1djweXwDpDPeg2aE9eN9BIpAA97ZSzxiOZF1RBXm4nK0MfgXl0soqbpwIFayLlonphRECoNduy4kN7fcw8.iDe7QgXxHkSS_u4LD6iU8NWxZwOjjEHXVHuGwQfIWSfQH8p3PZyGchsuBPY4ip5hSXcCrF7QlSdqGT1.zloPEHUphQOB5KpesTgFw3mDSMG7VEI2ayUe9KA8coet.zFCoe4tbZH4k0pRSKk4LS0IhJgExc3t2cGe.6IjjH3Snue3XM0cdkt49x2XCVXMMYAkMc1dDawC0BFc4r1vyqa1UueE483zPEQBqo4Sl6BM86XrZ9_M6XbFVlg1HdlJvjvqYc1I7kHkFH2Yx5O7jGG7W43u_LdaKihHzUikrzItaHxzvPh8c2M8R1q9V6cV77Vk5Z2wNIWUfmoaodvRxJe1MyctWf1NWFdqQja.hpTUV1IXiRAn2d0Z5gAJxMDM7Gm5_FDWR9w_UW0MyHaFwiqqQDAEtQXyT7C5JQ1UkwrmegisUwfeiXSOw9SQZbTWAVjeiDSAmsSLUnj2D9gJ8h_Pye6fGh_aoP6zhFMURBumZFQDjjitvQ91mEks90N0XdZ.CSHNSuyPIJ8xcr95a5ILmOztcWowjR6IMRL2xaPFKiXUl.GXDFaFivXmd7sBsxm6EZe1VZdpR.KlTCUhqRirevML3dS.kk7CFLJZtM18o4mnGYX63dQddyr_hOyyaepZYeY05ZZXKdRes_6RP.ull3O.S7sxCDIbL0Z975gzget0u7hsmCOsu558pP6Di7kByOa0fN27r7ofm5uy3bZdDcA_YsVNxNTgEFteWYeWWBb5pcYisXoQAgc8o1amDj_RQyEFC0XOjOiab3VrHHYCQeeWv3uW_2jftLk7jPIpW6rEAQ2P6JT_ulfUc1uaMGxhmJH8XuJdKV1LOuh.2hcXuXtXxs6yu.El6tpDQHoOaKWdy94Te51nruHJrcBIAcOAA2VF3jY1AvZ3iV3j9gj8Ffd5KJf3UXSOcV0kuXpz51EToCzzwxeRfgbQ3ZTU8PtpEb4ZnqhrfSDi2.XUkFxmLsejDugnxRLFZ_4j3Zl2MP3Z53RRyuLkFkvgLXDCyRBQgaqByO3WIiMaygQuqowSWQGSd3CL5ubKFXJ7ViAC1Rr7UPR1YfGnFMIPCZ5IjETrsfUdHLlszEwTPDh2sD.cldUn0fXxPIPzezy3w4wBmv7LmW4trnGUyIxMDbo4GLAEywicFEF4wlQBRETG1MpvUoNpaxHcUmwYCgQqmJpA7YsLtgHTrG3uaNEJLCEqsdifVBB.pise5ePp2CLhTRf_5Vx8GsTLG_8eArGumdAxHD4AaMnKUT5e8ECzLjSQnk2HQK1ZQa2QFVwOP6eKiEPvGR55xJTQ5rnhSrHoOLTwIAiQGCA207v7p59NqopkdARcgTYuT8oNiAmxezdTWILIy0eixzGyCOaad7UsdrirCBb3T.IjvFyi9jPm_gnzFpuqHVcHzTX1Ys1c5uKDHXcoBWfgBeZMHCs9Lqf2xJJWdk5sE5bV2863eZypwU8P5_MgsPbTkjhrhI0qSGrTS_jZUaAi8xmRbZgyS.GWb1uYzhuiA59jJMRQngC0r7XuV1jJi__NhrQvGpYmhCPasQ5dWjav3B.OO1YPpeCMH0bg2t2s850Bj6dH4XnnOx2GqF8trm8cze2n.t1JXxvtag"};var cpo = document.createElement('script');cpo.src = '/cdn-cgi/challenge-platform/h/b/orchestrate/chl_page/v1?ray=913498c84864fe0c';window._cf_chl_opt.cOgUHash = location.hash === '' && location.href.indexOf('#') !== -1 ? '#' : location.hash;window._cf_chl_opt.cOgUQuery = location.search === '' && location.href.slice(0, location.href.length - window._cf_chl_opt.cOgUHash.length).indexOf('?') !== -1 ? '?' : location.search;if (window.history && window.history.replaceState) {var ogU = location.pathname + window._cf_chl_opt.cOgUQuery + window._cf_chl_opt.cOgUHash;history.replaceState(null, null, "\/abstracts\/57804\/effect-on-tolerability-and-adverse-events-in-participants-receiving-naltrexonebupropion-and-antidepressant-medication-including-ssris-in-a-large-randomized-double-blind-study?__cf_chl_rt_tk=BMPyuTT39ZiZoo6U8Af3MsdgRdUWbL6.vcAGo3o.Z00-1739782928-1.0.1.1-_iyWjpfimUJGEUAjpZV3HOo6hchJnY5Y_c84BsOR7FA" + window._cf_chl_opt.cOgUHash);cpo.onload = function() {history.replaceState(null, null, ogU);}}document.getElementsByTagName('head')[0].appendChild(cpo);}());</script></body></html>